Product Information
OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.2393 per EA under NDC 33342017410. Its NADAC has been published 112 times since Jul 3, 2024.
FDA first approved this application on Jun 1, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB
OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDEStrength
12.5; 40 mg/1; mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342017410
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA204801FDA Approved
6/1/2023
TE Code
AB
On Market Since
6/2/2023
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB has been published 112 times since Jul 3, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2393 per EA |
|---|---|
| All-time high | $0.2503 (Oct 16, 2024) |
| All-time low | $0.1793 (Nov 20, 2024) |
| 52-week high | $0.2393 |
| 52-week low | $0.2149 |
| Median price | $0.2323 |
| Average price | $0.2302 |
| Largest weekly change | -26.4% (Nov 20, 2024) |
| Weeks tracked | 112 |
| Tracking since | Jul 3, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB, manufactured by Macleods Pharmaceuticals Limited, is $0.2393 per EA (NDC 33342017410), effective Aug 19, 2026.
How has the price of OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB has held within roughly two percent of its current level. It has been tracked across 112 weekly CMS publications since Jul 3, 2024.
What are the highest and lowest recorded NADAC prices for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB?
Since Jul 3, 2024, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB has ranged from a low of $0.1793 (Nov 20, 2024) to a high of $0.2503 (Oct 16, 2024), with a median of $0.2323 per EA.
Are there cheaper alternatives to OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB?
OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB (NDC 33342017410) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.